Why split Reckitt Benckiser?
  • 5 years ago
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs

Reckitt Benckiser is demerging its pharmaceuticals division with a planned listing of the renamed Indivior by Christmas. Lex’s Robert Armstrong and Oliver Ralph discuss why RB has split when there appears to be little value to unlock.


Make better investment decisions with Lex
http://www.ft.com/lex

Click here for more Lex videos
http://video.ft.com/Lex

For more video content from the Financial Times, visit http://www.FT.com/video

Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes